These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 1168122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Ebel H, Lübke H, Klaus D, Zehner J, Witzgall H.
    Dtsch Med Wochenschr; 1978 Oct 20; 103(42):1650-5. PubMed ID: 699788
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F, Leya A.
    Schweiz Rundsch Med Prax; 1981 Dec 08; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F, Braun B, Klaus D, Lemke R, Zehner J.
    Dtsch Med Wochenschr; 1976 Oct 08; 101(41):1482-8. PubMed ID: 183943
    [Abstract] [Full Text] [Related]

  • 5. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI.
    Br Med J; 1972 Jun 24; 2(5816):729-34. PubMed ID: 4338668
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K, Morimoto S, Takeda R, Murakami M.
    Jpn Circ J; 1972 Dec 24; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract] [Full Text] [Related]

  • 8. Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension.
    Hollifield JW.
    South Med J; 1976 Aug 24; 69(8):1034-6. PubMed ID: 785608
    [Abstract] [Full Text] [Related]

  • 9. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS, Johnson CA, Kotchen JM, Kotchen TA.
    Clin Pharmacol Ther; 1977 Jul 24; 22(1):14-20. PubMed ID: 326459
    [Abstract] [Full Text] [Related]

  • 10. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
    Gross E, Rothstein M, Dombek S, Juknis HI.
    Am J Kidney Dis; 2005 Jul 24; 46(1):94-101. PubMed ID: 15983962
    [Abstract] [Full Text] [Related]

  • 11. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 12. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
    Karlberg BE, Kågedal B, Tegler L, Tolagen K, Bergman B.
    Am J Cardiol; 1976 Mar 31; 37(4):642-9. PubMed ID: 769527
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low-renin hypertension. Restoration of normotension and renin responsiveness.
    Spark RF, O'Hare CM, Regan RM.
    Arch Intern Med; 1974 Feb 31; 133(2):205-11. PubMed ID: 4591266
    [No Abstract] [Full Text] [Related]

  • 15. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN, Zweifler AJ, Hansson L, Schork MA, Ellis C.
    Aust N Z J Med; 1975 Feb 31; 5(1):17-24. PubMed ID: 1057909
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
    Acchiardo S, Dustan HP, Tarazi RC.
    Cleve Clin Q; 1972 Feb 31; 39(4):153-62. PubMed ID: 4660197
    [No Abstract] [Full Text] [Related]

  • 18. Reduced response of plasma aldosterone to acute ACTH stimulation during long-term treatment with spironolactone in essential hypertension.
    Kim KS, Morimoto S, Uchida K, Miyamori I, Miyamoto M, Takeda R.
    Horm Res; 1979 Feb 31; 11(1):4-11. PubMed ID: 225255
    [Abstract] [Full Text] [Related]

  • 19. Role of renin classification for diuretic treatment of black hypertensive patients.
    Holland OB, Gomez-Sanchez C, Fairchild C, Kaplan NM.
    Arch Intern Med; 1979 Dec 31; 139(12):1365-70. PubMed ID: 518220
    [Abstract] [Full Text] [Related]

  • 20. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG, Hollifield JW, Liddle GW.
    JAMA; 1974 Feb 04; 227(5):518-21. PubMed ID: 4589187
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.